HCPLive Network
  • ACTRIMS-ECTRIMS 2014
  • Chronic Pain Peer Exchange Video Series
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Wednesday, September 17, 2014
By Adam Hochron
The outbreak of the Ebola virus in West Africa is showing no signs of slowing down. As a result, President Barack Obama announced Tuesday that the United States would be getting even more directly involved in the effort to contain the outbreak and prevent it from spreading any further.
Sunday, September 21, 2014
By HCPLive staff
Study results show that patients diagnosed with fibromyalgia often discontinue treatment. Those that do not frequently augment their initial treatment regimen with one or more additional medications, including some that are not recommended by current guidelines.
Sunday, September 21, 2014
By HCPLive staff
The patient-reported painDETECT questionnaire has been shown to accurately and reliably identify neuropathic pain across a range of conditions.
Sunday, September 21, 2014
By Kristine Nally, BS
Knowledge of dietary supplement properties, uses, and contraindications is highly relevant to any health care practitioner that treats patients with chronic pain. Data shows that the top four reasons for supplement use are back pain, neck pain, joint pain, and arthritis.
Saturday, September 20, 2014
By Kristine Nally, BS
Research indicates that there are probable etiologies of low back pain that can affect treatment outcome and that ignoring pain can possibly cause chronic neurological changes.
Saturday, September 20, 2014
By Kristine Nally, BS
Researchers are learning more about the ways in which gut microbiota interact with the central nervous system and the role this can play in pain management.
Saturday, September 20, 2014
By Kristine Nally, BS
Although the underlying mechanisms are not fully understood, opioid-induced hyperalgesia occurs in some patients on higher doses of opioids. Treatment options include reducing, rotating, or completely tapering the opioid regimen.
Friday, September 19, 2014
By Amy Jacob
Magnetic resonance is an effective alternative to biopsy for identifying and quantifying fats in the liver, according to results from a study led by a research team at the University of the Basque Country.
Friday, September 19, 2014
Daily supplements of selenium or vitamin E don't seem to protect against the development of age-related cataracts among men, according to a study published online Sept. 18 in JAMA Ophthalmology.
Friday, September 19, 2014
By Gale Scott
Workplace flu shots are a good investment, a new survey found. The US Centers for Disease Control and Prevention (CDC) on Sept. 19 urged all health care personnel to get flu vaccinations. The CDC also released the results of a survey of 1,882 health care clinicians meant to determine what factors influenced those who got the shots. Among its findings, when workplaces offered free shots on-site, compliance was 61.6% when the vaccinations were offered for one day only. When they were offered for multiple days, compliance rose to 80.4%. When employers did not offer the shots at all, compliance dropped to 49.0%
Email Signup
Physician's Money Digest
The Veterans Administration hopes a new pay scale will help the agency recruit new physicians and dentists and improve the services the embattled agency provides to veterans.
As Scotland moves forward from its rejection of independence, Eric Anderson, MD, profiles a physician who's made a name for himself playing a uniquely Scottish instrument -- the bagpipes.
Product News
Trulicity (dulaglutide) is a once-weekly subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
Stendra (avanafil) is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.
The FDA has approved Baxter’s Rixubis [Coagulation Factor IX (Recombinant)], an intravenous prophylactic treatment intended to control and prevent bleeding episodes and assist with perioperative management for children 12 years and younger with hemophilia B.
Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) is a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.
GeNeuro, a Swiss company specializing in promising therapies for neurological disorders, recently announced positive results from a Phase IIa study of a new drug for multiple sclerosis (MS).
HCPLive Poll
Twitter Advice
Have you ever given medical or financial advice on Twitter?